nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—AOX1—Methotrexate—psoriatic arthritis	0.266	0.404	CbGbCtD
Zaleplon—CYP3A7—Dexamethasone—psoriatic arthritis	0.0668	0.101	CbGbCtD
Zaleplon—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0668	0.101	CbGbCtD
Zaleplon—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0517	0.0785	CbGbCtD
Zaleplon—CYP3A5—Dexamethasone—psoriatic arthritis	0.0501	0.0761	CbGbCtD
Zaleplon—CYP3A4—Triamcinolone—psoriatic arthritis	0.0392	0.0595	CbGbCtD
Zaleplon—CYP3A4—Betamethasone—psoriatic arthritis	0.0336	0.051	CbGbCtD
Zaleplon—CYP3A4—Prednisolone—psoriatic arthritis	0.0331	0.0504	CbGbCtD
Zaleplon—CYP3A4—Prednisone—psoriatic arthritis	0.0313	0.0476	CbGbCtD
Zaleplon—CYP3A4—Dexamethasone—psoriatic arthritis	0.0195	0.0297	CbGbCtD
Zaleplon—Vertigo—Methylprednisolone—psoriatic arthritis	0.000399	0.00117	CcSEcCtD
Zaleplon—Syncope—Methylprednisolone—psoriatic arthritis	0.000398	0.00116	CcSEcCtD
Zaleplon—Oedema—Prednisolone—psoriatic arthritis	0.000395	0.00115	CcSEcCtD
Zaleplon—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000395	0.00115	CcSEcCtD
Zaleplon—Dysuria—Methotrexate—psoriatic arthritis	0.000394	0.00115	CcSEcCtD
Zaleplon—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000391	0.00114	CcSEcCtD
Zaleplon—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00039	0.00114	CcSEcCtD
Zaleplon—Shock—Prednisolone—psoriatic arthritis	0.000388	0.00114	CcSEcCtD
Zaleplon—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.000388	0.00114	CcSEcCtD
Zaleplon—Tachycardia—Prednisolone—psoriatic arthritis	0.000385	0.00113	CcSEcCtD
Zaleplon—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000385	0.00113	CcSEcCtD
Zaleplon—Hypertension—Triamcinolone—psoriatic arthritis	0.000384	0.00112	CcSEcCtD
Zaleplon—Hypertension—Methylprednisolone—psoriatic arthritis	0.000383	0.00112	CcSEcCtD
Zaleplon—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000381	0.00112	CcSEcCtD
Zaleplon—Myalgia—Triamcinolone—psoriatic arthritis	0.000379	0.00111	CcSEcCtD
Zaleplon—Pneumonia—Methotrexate—psoriatic arthritis	0.000378	0.00111	CcSEcCtD
Zaleplon—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000378	0.00111	CcSEcCtD
Zaleplon—Myalgia—Methylprednisolone—psoriatic arthritis	0.000378	0.00111	CcSEcCtD
Zaleplon—Eye disorder—Prednisone—psoriatic arthritis	0.000377	0.0011	CcSEcCtD
Zaleplon—Anxiety—Methylprednisolone—psoriatic arthritis	0.000376	0.0011	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000375	0.0011	CcSEcCtD
Zaleplon—Depression—Methotrexate—psoriatic arthritis	0.000375	0.0011	CcSEcCtD
Zaleplon—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000374	0.0011	CcSEcCtD
Zaleplon—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000374	0.0011	CcSEcCtD
Zaleplon—Discomfort—Triamcinolone—psoriatic arthritis	0.000374	0.00109	CcSEcCtD
Zaleplon—Discomfort—Methylprednisolone—psoriatic arthritis	0.000373	0.00109	CcSEcCtD
Zaleplon—Dry mouth—Triamcinolone—psoriatic arthritis	0.00037	0.00108	CcSEcCtD
Zaleplon—Angioedema—Dexamethasone—psoriatic arthritis	0.000369	0.00108	CcSEcCtD
Zaleplon—Angioedema—Betamethasone—psoriatic arthritis	0.000369	0.00108	CcSEcCtD
Zaleplon—Stomatitis—Methotrexate—psoriatic arthritis	0.000366	0.00107	CcSEcCtD
Zaleplon—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000365	0.00107	CcSEcCtD
Zaleplon—Confusional state—Methylprednisolone—psoriatic arthritis	0.000365	0.00107	CcSEcCtD
Zaleplon—Immune system disorder—Prednisone—psoriatic arthritis	0.000365	0.00107	CcSEcCtD
Zaleplon—Malaise—Dexamethasone—psoriatic arthritis	0.000364	0.00106	CcSEcCtD
Zaleplon—Malaise—Betamethasone—psoriatic arthritis	0.000364	0.00106	CcSEcCtD
Zaleplon—Oedema—Triamcinolone—psoriatic arthritis	0.000363	0.00106	CcSEcCtD
Zaleplon—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000363	0.00106	CcSEcCtD
Zaleplon—Vertigo—Betamethasone—psoriatic arthritis	0.000362	0.00106	CcSEcCtD
Zaleplon—Vertigo—Dexamethasone—psoriatic arthritis	0.000362	0.00106	CcSEcCtD
Zaleplon—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000362	0.00106	CcSEcCtD
Zaleplon—Syncope—Dexamethasone—psoriatic arthritis	0.000362	0.00106	CcSEcCtD
Zaleplon—Syncope—Betamethasone—psoriatic arthritis	0.000362	0.00106	CcSEcCtD
Zaleplon—Sweating—Methotrexate—psoriatic arthritis	0.00036	0.00105	CcSEcCtD
Zaleplon—Haematuria—Methotrexate—psoriatic arthritis	0.000358	0.00105	CcSEcCtD
Zaleplon—Shock—Triamcinolone—psoriatic arthritis	0.000357	0.00104	CcSEcCtD
Zaleplon—Insomnia—Prednisolone—psoriatic arthritis	0.000357	0.00104	CcSEcCtD
Zaleplon—Alopecia—Prednisone—psoriatic arthritis	0.000357	0.00104	CcSEcCtD
Zaleplon—Shock—Methylprednisolone—psoriatic arthritis	0.000356	0.00104	CcSEcCtD
Zaleplon—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000355	0.00104	CcSEcCtD
Zaleplon—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000355	0.00104	CcSEcCtD
Zaleplon—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000355	0.00104	CcSEcCtD
Zaleplon—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000355	0.00104	CcSEcCtD
Zaleplon—Epistaxis—Methotrexate—psoriatic arthritis	0.000354	0.00104	CcSEcCtD
Zaleplon—Paraesthesia—Prednisolone—psoriatic arthritis	0.000354	0.00104	CcSEcCtD
Zaleplon—Tachycardia—Triamcinolone—psoriatic arthritis	0.000354	0.00104	CcSEcCtD
Zaleplon—Mental disorder—Prednisone—psoriatic arthritis	0.000354	0.00103	CcSEcCtD
Zaleplon—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000353	0.00103	CcSEcCtD
Zaleplon—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000352	0.00103	CcSEcCtD
Zaleplon—Malnutrition—Prednisone—psoriatic arthritis	0.000351	0.00103	CcSEcCtD
Zaleplon—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000351	0.00103	CcSEcCtD
Zaleplon—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00035	0.00102	CcSEcCtD
Zaleplon—Hypertension—Dexamethasone—psoriatic arthritis	0.000348	0.00102	CcSEcCtD
Zaleplon—Hypertension—Betamethasone—psoriatic arthritis	0.000348	0.00102	CcSEcCtD
Zaleplon—Myalgia—Betamethasone—psoriatic arthritis	0.000343	0.00101	CcSEcCtD
Zaleplon—Myalgia—Dexamethasone—psoriatic arthritis	0.000343	0.00101	CcSEcCtD
Zaleplon—Anxiety—Dexamethasone—psoriatic arthritis	0.000342	0.001	CcSEcCtD
Zaleplon—Anxiety—Betamethasone—psoriatic arthritis	0.000342	0.001	CcSEcCtD
Zaleplon—Discomfort—Dexamethasone—psoriatic arthritis	0.000339	0.000993	CcSEcCtD
Zaleplon—Discomfort—Betamethasone—psoriatic arthritis	0.000339	0.000993	CcSEcCtD
Zaleplon—Hypotension—Methylprednisolone—psoriatic arthritis	0.000338	0.00099	CcSEcCtD
Zaleplon—Pain—Prednisolone—psoriatic arthritis	0.000337	0.000988	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000331	0.000968	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00033	0.000965	CcSEcCtD
Zaleplon—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000329	0.000964	CcSEcCtD
Zaleplon—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000329	0.000964	CcSEcCtD
Zaleplon—Oedema—Betamethasone—psoriatic arthritis	0.000329	0.000964	CcSEcCtD
Zaleplon—Oedema—Dexamethasone—psoriatic arthritis	0.000329	0.000964	CcSEcCtD
Zaleplon—Insomnia—Triamcinolone—psoriatic arthritis	0.000328	0.000961	CcSEcCtD
Zaleplon—Insomnia—Methylprednisolone—psoriatic arthritis	0.000327	0.000958	CcSEcCtD
Zaleplon—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000326	0.000954	CcSEcCtD
Zaleplon—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000326	0.000954	CcSEcCtD
Zaleplon—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000325	0.000952	CcSEcCtD
Zaleplon—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000325	0.000952	CcSEcCtD
Zaleplon—Visual impairment—Methotrexate—psoriatic arthritis	0.000325	0.000951	CcSEcCtD
Zaleplon—Anaemia—Prednisone—psoriatic arthritis	0.000325	0.00095	CcSEcCtD
Zaleplon—Shock—Betamethasone—psoriatic arthritis	0.000324	0.000948	CcSEcCtD
Zaleplon—Shock—Dexamethasone—psoriatic arthritis	0.000324	0.000948	CcSEcCtD
Zaleplon—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000324	0.000947	CcSEcCtD
Zaleplon—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000323	0.000945	CcSEcCtD
Zaleplon—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000323	0.000945	CcSEcCtD
Zaleplon—Agitation—Prednisone—psoriatic arthritis	0.000323	0.000945	CcSEcCtD
Zaleplon—Tachycardia—Betamethasone—psoriatic arthritis	0.000321	0.00094	CcSEcCtD
Zaleplon—Tachycardia—Dexamethasone—psoriatic arthritis	0.000321	0.00094	CcSEcCtD
Zaleplon—Angioedema—Prednisone—psoriatic arthritis	0.000321	0.00094	CcSEcCtD
Zaleplon—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000319	0.000935	CcSEcCtD
Zaleplon—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000319	0.000933	CcSEcCtD
Zaleplon—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000318	0.000932	CcSEcCtD
Zaleplon—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000318	0.000932	CcSEcCtD
Zaleplon—Malaise—Prednisone—psoriatic arthritis	0.000317	0.000927	CcSEcCtD
Zaleplon—Vertigo—Prednisone—psoriatic arthritis	0.000316	0.000924	CcSEcCtD
Zaleplon—Eye disorder—Methotrexate—psoriatic arthritis	0.000315	0.000923	CcSEcCtD
Zaleplon—Syncope—Prednisone—psoriatic arthritis	0.000315	0.000922	CcSEcCtD
Zaleplon—Tinnitus—Methotrexate—psoriatic arthritis	0.000314	0.00092	CcSEcCtD
Zaleplon—Anorexia—Betamethasone—psoriatic arthritis	0.000314	0.000919	CcSEcCtD
Zaleplon—Anorexia—Dexamethasone—psoriatic arthritis	0.000314	0.000919	CcSEcCtD
Zaleplon—Urticaria—Prednisolone—psoriatic arthritis	0.000313	0.000917	CcSEcCtD
Zaleplon—Pain—Triamcinolone—psoriatic arthritis	0.00031	0.000908	CcSEcCtD
Zaleplon—Loss of consciousness—Prednisone—psoriatic arthritis	0.000309	0.000904	CcSEcCtD
Zaleplon—Hypotension—Betamethasone—psoriatic arthritis	0.000308	0.0009	CcSEcCtD
Zaleplon—Hypotension—Dexamethasone—psoriatic arthritis	0.000308	0.0009	CcSEcCtD
Zaleplon—Immune system disorder—Methotrexate—psoriatic arthritis	0.000305	0.000892	CcSEcCtD
Zaleplon—Hypertension—Prednisone—psoriatic arthritis	0.000303	0.000888	CcSEcCtD
Zaleplon—Chills—Methotrexate—psoriatic arthritis	0.000303	0.000886	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.0003	0.000878	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.0003	0.000878	CcSEcCtD
Zaleplon—Myalgia—Prednisone—psoriatic arthritis	0.000299	0.000875	CcSEcCtD
Zaleplon—Arthralgia—Prednisone—psoriatic arthritis	0.000299	0.000875	CcSEcCtD
Zaleplon—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000299	0.000875	CcSEcCtD
Zaleplon—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000298	0.000873	CcSEcCtD
Zaleplon—Anxiety—Prednisone—psoriatic arthritis	0.000298	0.000872	CcSEcCtD
Zaleplon—Alopecia—Methotrexate—psoriatic arthritis	0.000298	0.000872	CcSEcCtD
Zaleplon—Insomnia—Dexamethasone—psoriatic arthritis	0.000298	0.000872	CcSEcCtD
Zaleplon—Insomnia—Betamethasone—psoriatic arthritis	0.000298	0.000872	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000297	0.000869	CcSEcCtD
Zaleplon—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000296	0.000867	CcSEcCtD
Zaleplon—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000296	0.000865	CcSEcCtD
Zaleplon—Paraesthesia—Betamethasone—psoriatic arthritis	0.000296	0.000865	CcSEcCtD
Zaleplon—Discomfort—Prednisone—psoriatic arthritis	0.000296	0.000865	CcSEcCtD
Zaleplon—Mental disorder—Methotrexate—psoriatic arthritis	0.000296	0.000865	CcSEcCtD
Zaleplon—Malnutrition—Methotrexate—psoriatic arthritis	0.000294	0.000859	CcSEcCtD
Zaleplon—Dyspepsia—Betamethasone—psoriatic arthritis	0.00029	0.000848	CcSEcCtD
Zaleplon—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00029	0.000848	CcSEcCtD
Zaleplon—Urticaria—Triamcinolone—psoriatic arthritis	0.000288	0.000844	CcSEcCtD
Zaleplon—Urticaria—Methylprednisolone—psoriatic arthritis	0.000288	0.000842	CcSEcCtD
Zaleplon—Dysgeusia—Methotrexate—psoriatic arthritis	0.000288	0.000842	CcSEcCtD
Zaleplon—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000287	0.00084	CcSEcCtD
Zaleplon—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000287	0.000839	CcSEcCtD
Zaleplon—Oedema—Prednisone—psoriatic arthritis	0.000287	0.000839	CcSEcCtD
Zaleplon—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000286	0.000838	CcSEcCtD
Zaleplon—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000286	0.000838	CcSEcCtD
Zaleplon—Decreased appetite—Betamethasone—psoriatic arthritis	0.000286	0.000838	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000284	0.000832	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000284	0.000832	CcSEcCtD
Zaleplon—Back pain—Methotrexate—psoriatic arthritis	0.000284	0.000831	CcSEcCtD
Zaleplon—Shock—Prednisone—psoriatic arthritis	0.000282	0.000826	CcSEcCtD
Zaleplon—Pain—Dexamethasone—psoriatic arthritis	0.000282	0.000824	CcSEcCtD
Zaleplon—Pain—Betamethasone—psoriatic arthritis	0.000282	0.000824	CcSEcCtD
Zaleplon—Nervous system disorder—Prednisone—psoriatic arthritis	0.000281	0.000823	CcSEcCtD
Zaleplon—Tachycardia—Prednisone—psoriatic arthritis	0.00028	0.000819	CcSEcCtD
Zaleplon—Skin disorder—Prednisone—psoriatic arthritis	0.000279	0.000815	CcSEcCtD
Zaleplon—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000277	0.000811	CcSEcCtD
Zaleplon—Anorexia—Prednisone—psoriatic arthritis	0.000273	0.0008	CcSEcCtD
Zaleplon—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000272	0.000797	CcSEcCtD
Zaleplon—Anaemia—Methotrexate—psoriatic arthritis	0.000271	0.000794	CcSEcCtD
Zaleplon—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000271	0.000794	CcSEcCtD
Zaleplon—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000271	0.000794	CcSEcCtD
Zaleplon—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000269	0.000788	CcSEcCtD
Zaleplon—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000269	0.000788	CcSEcCtD
Zaleplon—Malaise—Methotrexate—psoriatic arthritis	0.000265	0.000775	CcSEcCtD
Zaleplon—Vertigo—Methotrexate—psoriatic arthritis	0.000264	0.000772	CcSEcCtD
Zaleplon—Urticaria—Dexamethasone—psoriatic arthritis	0.000262	0.000766	CcSEcCtD
Zaleplon—Urticaria—Betamethasone—psoriatic arthritis	0.000262	0.000766	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000261	0.000765	CcSEcCtD
Zaleplon—Dizziness—Prednisolone—psoriatic arthritis	0.000261	0.000764	CcSEcCtD
Zaleplon—Asthenia—Triamcinolone—psoriatic arthritis	0.00026	0.000762	CcSEcCtD
Zaleplon—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00026	0.000762	CcSEcCtD
Zaleplon—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00026	0.000762	CcSEcCtD
Zaleplon—Body temperature increased—Betamethasone—psoriatic arthritis	0.00026	0.000762	CcSEcCtD
Zaleplon—Abdominal pain—Betamethasone—psoriatic arthritis	0.00026	0.000762	CcSEcCtD
Zaleplon—Asthenia—Methylprednisolone—psoriatic arthritis	0.00026	0.00076	CcSEcCtD
Zaleplon—Insomnia—Prednisone—psoriatic arthritis	0.000259	0.000759	CcSEcCtD
Zaleplon—Paraesthesia—Prednisone—psoriatic arthritis	0.000257	0.000754	CcSEcCtD
Zaleplon—Pruritus—Triamcinolone—psoriatic arthritis	0.000257	0.000751	CcSEcCtD
Zaleplon—Pruritus—Methylprednisolone—psoriatic arthritis	0.000256	0.00075	CcSEcCtD
Zaleplon—Dyspepsia—Prednisone—psoriatic arthritis	0.000252	0.000739	CcSEcCtD
Zaleplon—Arthralgia—Methotrexate—psoriatic arthritis	0.00025	0.000732	CcSEcCtD
Zaleplon—Chest pain—Methotrexate—psoriatic arthritis	0.00025	0.000732	CcSEcCtD
Zaleplon—Myalgia—Methotrexate—psoriatic arthritis	0.00025	0.000732	CcSEcCtD
Zaleplon—Decreased appetite—Prednisone—psoriatic arthritis	0.000249	0.00073	CcSEcCtD
Zaleplon—Rash—Prednisolone—psoriatic arthritis	0.000249	0.000728	CcSEcCtD
Zaleplon—Dermatitis—Prednisolone—psoriatic arthritis	0.000249	0.000727	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000248	0.000727	CcSEcCtD
Zaleplon—Headache—Prednisolone—psoriatic arthritis	0.000247	0.000723	CcSEcCtD
Zaleplon—Discomfort—Methotrexate—psoriatic arthritis	0.000247	0.000723	CcSEcCtD
Zaleplon—Constipation—Prednisone—psoriatic arthritis	0.000245	0.000718	CcSEcCtD
Zaleplon—Confusional state—Methotrexate—psoriatic arthritis	0.000242	0.000707	CcSEcCtD
Zaleplon—Dizziness—Triamcinolone—psoriatic arthritis	0.00024	0.000702	CcSEcCtD
Zaleplon—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00024	0.000701	CcSEcCtD
Zaleplon—Dizziness—Methylprednisolone—psoriatic arthritis	0.000239	0.000701	CcSEcCtD
Zaleplon—Feeling abnormal—Prednisone—psoriatic arthritis	0.000236	0.000692	CcSEcCtD
Zaleplon—Asthenia—Betamethasone—psoriatic arthritis	0.000236	0.000691	CcSEcCtD
Zaleplon—Asthenia—Dexamethasone—psoriatic arthritis	0.000236	0.000691	CcSEcCtD
Zaleplon—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000235	0.000688	CcSEcCtD
Zaleplon—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000234	0.000686	CcSEcCtD
Zaleplon—Nausea—Prednisolone—psoriatic arthritis	0.000234	0.000686	CcSEcCtD
Zaleplon—Pruritus—Betamethasone—psoriatic arthritis	0.000233	0.000682	CcSEcCtD
Zaleplon—Pruritus—Dexamethasone—psoriatic arthritis	0.000233	0.000682	CcSEcCtD
Zaleplon—Skin disorder—Methotrexate—psoriatic arthritis	0.000233	0.000681	CcSEcCtD
Zaleplon—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000232	0.000678	CcSEcCtD
Zaleplon—Rash—Triamcinolone—psoriatic arthritis	0.000229	0.00067	CcSEcCtD
Zaleplon—Dermatitis—Triamcinolone—psoriatic arthritis	0.000229	0.000669	CcSEcCtD
Zaleplon—Anorexia—Methotrexate—psoriatic arthritis	0.000228	0.000669	CcSEcCtD
Zaleplon—Rash—Methylprednisolone—psoriatic arthritis	0.000228	0.000668	CcSEcCtD
Zaleplon—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000228	0.000668	CcSEcCtD
Zaleplon—Urticaria—Prednisone—psoriatic arthritis	0.000228	0.000667	CcSEcCtD
Zaleplon—Headache—Triamcinolone—psoriatic arthritis	0.000227	0.000665	CcSEcCtD
Zaleplon—Headache—Methylprednisolone—psoriatic arthritis	0.000227	0.000664	CcSEcCtD
Zaleplon—Abdominal pain—Prednisone—psoriatic arthritis	0.000227	0.000663	CcSEcCtD
Zaleplon—Body temperature increased—Prednisone—psoriatic arthritis	0.000227	0.000663	CcSEcCtD
Zaleplon—Hypotension—Methotrexate—psoriatic arthritis	0.000224	0.000655	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000218	0.000639	CcSEcCtD
Zaleplon—Dizziness—Betamethasone—psoriatic arthritis	0.000218	0.000637	CcSEcCtD
Zaleplon—Dizziness—Dexamethasone—psoriatic arthritis	0.000218	0.000637	CcSEcCtD
Zaleplon—Insomnia—Methotrexate—psoriatic arthritis	0.000217	0.000634	CcSEcCtD
Zaleplon—Nausea—Triamcinolone—psoriatic arthritis	0.000216	0.000631	CcSEcCtD
Zaleplon—Paraesthesia—Methotrexate—psoriatic arthritis	0.000215	0.00063	CcSEcCtD
Zaleplon—Nausea—Methylprednisolone—psoriatic arthritis	0.000215	0.000629	CcSEcCtD
Zaleplon—Dyspnoea—Methotrexate—psoriatic arthritis	0.000214	0.000625	CcSEcCtD
Zaleplon—Somnolence—Methotrexate—psoriatic arthritis	0.000213	0.000623	CcSEcCtD
Zaleplon—Dyspepsia—Methotrexate—psoriatic arthritis	0.000211	0.000617	CcSEcCtD
Zaleplon—Decreased appetite—Methotrexate—psoriatic arthritis	0.000208	0.00061	CcSEcCtD
Zaleplon—Rash—Betamethasone—psoriatic arthritis	0.000208	0.000608	CcSEcCtD
Zaleplon—Rash—Dexamethasone—psoriatic arthritis	0.000208	0.000608	CcSEcCtD
Zaleplon—Dermatitis—Betamethasone—psoriatic arthritis	0.000207	0.000607	CcSEcCtD
Zaleplon—Dermatitis—Dexamethasone—psoriatic arthritis	0.000207	0.000607	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000207	0.000605	CcSEcCtD
Zaleplon—Headache—Betamethasone—psoriatic arthritis	0.000206	0.000604	CcSEcCtD
Zaleplon—Headache—Dexamethasone—psoriatic arthritis	0.000206	0.000604	CcSEcCtD
Zaleplon—Asthenia—Prednisone—psoriatic arthritis	0.000206	0.000602	CcSEcCtD
Zaleplon—Pain—Methotrexate—psoriatic arthritis	0.000205	0.0006	CcSEcCtD
Zaleplon—Pruritus—Prednisone—psoriatic arthritis	0.000203	0.000594	CcSEcCtD
Zaleplon—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000197	0.000578	CcSEcCtD
Zaleplon—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000196	0.000574	CcSEcCtD
Zaleplon—Nausea—Dexamethasone—psoriatic arthritis	0.000196	0.000572	CcSEcCtD
Zaleplon—Nausea—Betamethasone—psoriatic arthritis	0.000196	0.000572	CcSEcCtD
Zaleplon—Urticaria—Methotrexate—psoriatic arthritis	0.00019	0.000557	CcSEcCtD
Zaleplon—Dizziness—Prednisone—psoriatic arthritis	0.00019	0.000555	CcSEcCtD
Zaleplon—Abdominal pain—Methotrexate—psoriatic arthritis	0.000189	0.000554	CcSEcCtD
Zaleplon—Body temperature increased—Methotrexate—psoriatic arthritis	0.000189	0.000554	CcSEcCtD
Zaleplon—Rash—Prednisone—psoriatic arthritis	0.000181	0.000529	CcSEcCtD
Zaleplon—Dermatitis—Prednisone—psoriatic arthritis	0.000181	0.000529	CcSEcCtD
Zaleplon—Headache—Prednisone—psoriatic arthritis	0.00018	0.000526	CcSEcCtD
Zaleplon—Asthenia—Methotrexate—psoriatic arthritis	0.000172	0.000503	CcSEcCtD
Zaleplon—Nausea—Prednisone—psoriatic arthritis	0.00017	0.000498	CcSEcCtD
Zaleplon—Pruritus—Methotrexate—psoriatic arthritis	0.00017	0.000496	CcSEcCtD
Zaleplon—Dizziness—Methotrexate—psoriatic arthritis	0.000158	0.000464	CcSEcCtD
Zaleplon—Rash—Methotrexate—psoriatic arthritis	0.000151	0.000442	CcSEcCtD
Zaleplon—Dermatitis—Methotrexate—psoriatic arthritis	0.000151	0.000442	CcSEcCtD
Zaleplon—Headache—Methotrexate—psoriatic arthritis	0.00015	0.000439	CcSEcCtD
Zaleplon—Nausea—Methotrexate—psoriatic arthritis	0.000142	0.000417	CcSEcCtD
